The discovery comes from England. In the meantime, it is still prescribed although it is useless and also has serious enough contraindications
Other governments also advise against treating teens with Tamiflu for neuropsychiatric risk. In Italy and other countries it is approved to prevent, block and treat type A and B flu, using the active ingredient Oseltamivir.
The British Medical Journal reveals the altar and ... the scam !!!
The British Medical Journal (BMJ) throws a stone into the pond. While the first cases of influenza have been reported in Italy, it suggests that Tamiflu, the main antiviral drug, is ineffective.
According to the British Medical Journal, Roche, the manufacturer of the famous Tamiflu, refuses to disclose the full results of its studies on the effectiveness of the antiviral. Results requested since 2009! Enough to leave some doubts about the content of these studies and therefore the effectiveness of Tamiflu himself….
Until now, it is only known that if the flu is ordinary, Tamiflu must be taken within 48 hours and reduces the duration of symptoms in 24 hours and acts particularly on people suffering from flu symptoms for more than 2 days. By contrast, in the case of a more serious flu, no studies have shown its efficiency ...
Observations during the 2009 epidemic, however, seem to show that taking Tamiflu reduced the death toll.
Although it says that Roche has made all clinical trial data available to national health authorities, the European Medicines Agency has confirmed that researchers do not have any evidence. Additionally, the antiviral drug Tamiflu, widely prescribed as a treatment for swine flu H1N1, produces neuropsychiatric side effects such as nightmares in nearly 20 percent of all children treated with it, according to a couple of studies conducted by UK researchers from Protection. Agency.
The Japanese government also advises against treating adolescents with Tamiflu for neuropsychiatric risk.
Currently, Tamiflu is administered to everyone in the United Kingdom in cases of swine flu infection. More than 150.000 people were treated with the drug during the last week of July alone.
The first study, published in the journal Eurosurveillance, looked at side effects in 85 London schoolchildren who had been previously treated with Tamiflu in April and May, after one of their classmates was diagnosed with swine flu. Forty-five of these children, about 53 percent, had at least one side effect. Twenty percent of the children suffered from nausea, stomach cramps, 20 percent pain and 12 percent had insomnia problems. Almost 20 per cent had at least one neuropsychiatric effect, such as nightmares, strange behaviors with loss of lucidity.
Similar results have been confirmed in a second study, conducted on students in the southwest.
The researchers noted that 20 percent of adults treated with Tamiflu suffer from nausea or vomiting.
Giovanni D'Agata, founder of the "Rights Window", highlights that the pharmaceutical company Roche is also investigated by the European Medicines Agency for the incorrect reporting of side effects, including possible deaths due to 19 drugs including Tamiflu which have been used on approximately 80.000 patients in the United States.